SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Streptomycetaceae Details: NCBI 2062, high G+C gram-positive [family]

| Actinoplanaceae| Actinoplanaceae Couch 1955| Streptomycetaceae| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Huang et al. 2017| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Kim et al. 2003| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Nouioui et al. 2018| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Rainey et al. 1997| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Zhi et al. 2009

  1. Production of antibiotics: Streptomyces species are prolific producers of antibiotics, many of which have been used clinically to treat bacterial infections in humans. Examples include streptomycin, tetracycline, erythromycin, and vancomycin. These antibiotics have played a crucial role in the treatment of various bacterial diseases, including tuberculosis, pneumonia, and skin infections.

  2. Antibiotic resistance: While Streptomyces species produce antibiotics that are effective against many bacterial pathogens, some bacteria have developed resistance to these antibiotics. Antibiotic resistance is a growing global health concern and poses challenges for the treatment of bacterial infections. Streptomyces bacteria themselves can harbor antibiotic resistance genes, and their interactions with other bacteria in the environment may contribute to the spread of antibiotic resistance.

  3. Potential for drug discovery: Streptomyces bacteria continue to be a rich source of bioactive compounds with potential pharmaceutical applications. Scientists study Streptomyces strains to identify novel antibiotics and other bioactive molecules that could be developed into new drugs for the treatment of infectious diseases, cancer, and other health conditions.

  4. Environmental interactions: While Streptomyces bacteria are primarily soil-dwelling microorganisms, they can also be found in various other environments, including water, plants, and animals. Streptomyces species interact with other microorganisms and their hosts in complex ways, influencing ecosystem dynamics and potentially impacting human health indirectly through their effects on environmental microbiota and ecosystems.

  5. Rare infections: Although Streptomyces species are not typically considered human pathogens, there have been rare reports of infections caused by these bacteria, particularly in immunocompromised individuals or those with underlying health conditions. These infections are often associated with traumatic injuries, surgical wounds, or exposure to contaminated environments.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Streptomycetaceae

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 1.63 6 5300 0 3983 1146.4 210 1447.3 0 4050 0 %ile 100 %ile
biomesight 18.48 0 10 10 670 0 1966 121 20 941.6 20 60 0 %ile 97.3 %ile
thorne 100 45 1127 0 727 286.4 199 224.7 85 431 0 %ile 100 %ile
thryve 22.02 0 11 1 189 0 83 31 23 26.4 11 47 0 %ile 100 %ile

External Reference Ranges for Streptomycetaceae

Streptomycetaceae (NCBI 2062) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 76.92 208.64 0.0077 0.0209
Statistic by Lab Source for Streptomycetaceae
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
AmericanGut 13.333 %   0.033 %  0.038 % 2.0 15
BiomeSight 18.75 %   0.011 %  0.085 % 537.0 2864
bugspeak 100 %   0.142 %  % 1.0 1
CerbaLab 66.667 %   0.005 %  0 % 2.0 3
custom 15.254 %   0.19 %  0.069 % 9.0 59
es-xenogene 100 %   0.163 %  0.161 % 29.0 29
Medivere 85.714 %   0.004 %  0.003 % 6.0 7
SequentiaBiotech 5.556 %   0.026 %  0.011 % 2.0 36
Thorne 85.227 %   0.051 %  0.12 % 75.0 88
Thryve 24.295 %   0.003 %  0.002 % 336.0 1383
Tiny 100 %   0.013 %  % 1.0 1

Symptoms Associated with Streptomycetaceae From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.

Foods Containing the Streptomycetaceae bacteria

Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.

Passito wine Weight: 0.05017 Malaysian fermented fish sauce Weight: 0.03395 Ham fermented for 4 years Weight: 0.02774 Chinese fish sauce Weight: 0.01578 yoghurt fermentation Weight: 0.003969 Sausage, Cyprus: Limassol Weight: 0.000556606924190136

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Probiotics Prescript Assist (2018 Formula) 3 Studies recorded. The consensus is Increases👶👪📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)